Zhejiang NHU Company Ltd. (SHE:002001)
China · Delayed Price · Currency is CNY 30.66
-0.41 (-1.32%)
Aug 11, 2026, 1:30 PM CST
Zhejiang NHU Company Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 23,106 | 22,251 | 21,610 | 15,117 | 15,934 | 14,917 |
Revenue Growth | 2.47% | 2.97% | 42.95% | -5.13% | 6.82% | 44.63% |
Gross Profit Gross Profit Growth | 9,870 | 9,711 | 8,978 | 4,754 | 5,723 | 6,592 |
Operating Income Operating Income Growth | 7,770 | 7,675 | 7,047 | 3,133 | 4,116 | 5,098 |
Net Income Net Income Growth | 6,712 | 6,764 | 5,869 | 2,704 | 3,620 | 4,356 |
Earnings Per Share EPS Growth | 2.19 | 2.21 | 1.91 | 0.87 | 1.17 | 1.41 |
EPS Growth | -2.37% | 15.71% | 119.54% | -25.64% | -17.02% | 22.61% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical and Chemical Engineering Pharmaceutical and Chemical Engineering Growth | 20,760 | 19,842 | 13,798 | 14,673 | 13,905 |
Others Others Growth | 2,330 | 1,768 | 1,319 | 1,261 | 1,012 |
Inter-Segment Offsetting Inter-Segment Offsetting Growth | -838.36 | - | - | - | - |
Total Total Growth | 22,251 | 21,610 | 15,117 | 15,934 | 14,917 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 11,978 | 10,135 | 7,937 | 4,716 | 6,064 | 7,754 |
Total Debt Total Debt Growth | 7,519 | 8,030 | 8,959 | 9,627 | 9,728 | 8,585 |
Net Cash (Debt) Net Cash Growth | 4,459 | 2,104 | -1,021 | -4,911 | -3,664 | -830.94 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.45 | 0.69 | -0.33 | -1.58 | -1.18 | -0.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 8,885 | 8,797 | 7,073 | 5,119 | 4,361 | 5,838 |
Capital Expenditures CapEx Growth | -1,954 | -1,900 | -1,600 | -4,446 | -4,932 | -3,473 |
Free Cash Flow Free Cash Flow Growth | 6,931 | 6,897 | 5,473 | 673.85 | -570.41 | 2,365 |
Free Cash Flow Growth | 0.86% | 26.01% | 712.24% | - | - | 207.21% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 42.72% | 43.64% | 41.55% | 31.45% | 35.91% | 44.19% |
Operating Margin | 33.63% | 34.49% | 32.61% | 20.73% | 25.83% | 34.18% |
Pretax Margin | 33.94% | 35.28% | 32.13% | 21.52% | 26.60% | 33.94% |
Profit Margin | 29.05% | 30.40% | 27.16% | 17.89% | 22.72% | 29.20% |
FCF Margin | 30.00% | 31.00% | 25.33% | 4.46% | -3.58% | 15.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.500 | 0.450 | 0.500 | 0.583 |
Dividend Per Share Growth | 42.86% | 100.00% | 11.11% | -10.00% | -14.28% | 20.00% |
Dividend Yield | 3.22% | 4.08% | 2.43% | 2.90% | 3.01% | 2.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 14.19 | 11.39 | 11.51 | 19.27 | 15.92 | 18.42 |
Forward PE | 10.18 | 12.20 | 11.17 | 13.87 | 13.53 | 18.83 |
P/FCF Ratio | 13.76 | 11.17 | 12.34 | 77.35 | - | 33.93 |
PS Ratio | 4.13 | 3.46 | 3.13 | 3.45 | 3.62 | 5.38 |